NASP Podcast: Clinical Overivew of TEZSPIRE(R) (tezepelumab-ekko) with Amgen

In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Dr Andrew Lindsley, US Medical Director at Amgen and Dr Ash Davé, Director, Medical Value and Population Health at Amgen, to discuss TEZSPIRE® (tezepelumab-ekko).

Click here to listen to another NASP Podcast episode with Amgen.